The large therapeutic market for chronic obstructive pulmonary disease (COPD), a...
The large therapeutic market for chronic obstructive pulmonary disease (COPD), a disease that is closely associated with smoking, continues to expand and is expected to grow from approximately $15......
The asthma market consists of many well-established therapies, including...
The asthma market consists of many well-established therapies, including inhaled agents (e.g., GlaxoSmithKline’s Advair/Seretide, AstraZeneca’s Symbicort, Boehringer Ingelheim...
DRG Epidemiology's coverage of AR comprises epidemiological estimates of...
DRG Epidemiology's coverage of AR comprises epidemiological estimates of key patient populations acro...
DRG Epidemiology’s coverage of acute respiratory distress syndrome (ARDS)...
DRG Epidemiology’s coverage of acute respiratory distress syndrome (ARDS) comprises ep...
DRG Epidemiology's coverage of OSA comprises epidemiological estimates of...
DRG Epidemiology's coverage of OSA comprises epidemiological estimates of key patient populations ac......
MARKET OUTLOOK COPD is a progressive inflammatory respiratory tract and lung...
MARKET OUTLOOK COPD is a progressive inflammatory respiratory tract and lung disease characterized by airflow......
Market Outlook The asthma market in the EU5 is highly competitive. A large...
Market Outlook The asthma market in the EU5 is highly competitive. A large number of approved agents are available inc......
Cystic fibrosis (CF) is a genetic disease caused by any one of the more than 2...
Cystic fibrosis (CF) is a genetic disease caused by any one of the more than 2,000 mutations identified in the cystic fibrosis transmembrane conductance regul......
DRG Epidemiology’s coverage of sarcoidosis comprises epidemiological...
DRG Epidemiology’s coverage of sarcoidosis comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany...
MARKET OUTLOOK The chronic obstructive pulmonary disease (COPD) market is...
MARKET OUTLOOK The chronic obstructive pulmonary disease (COPD) market is experiencing increased competition a......
ARDS is an acute, severe lung injury that causes edema of the lung alveoli,...
ARDS is an acute, severe lung injury that causes edema of the lung alveoli, leading to breathing abnormalities and insufficient oxyge...
DRG Epidemiology's coverage of asthma comprises epidemiological estimates...
DRG Epidemiology's coverage of asthma comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of asthma for each country as well......
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of asthma for each country, as well...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of asthma for each country, as...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of asthma for each country, as...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of...
DRG Epidemiology’s coverage of asthma comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of asthma for each country, as...
DRG Epidemiology’s coverage of chronic obstructive pulmonary disease (COPD)...
DRG Epidemiology’s coverage of chronic obstructive pulmonary disease (COPD) comprises epidemiological estimates of key patient populations in&n...
DRG Epidemiology’s coverage of chronic obstructive pulmonary disease (COPD)...
DRG Epidemiology’s coverage of chronic obstructive pulmonary disease (COPD) comprise...
DRG Epidemiology’s coverage of chronic obstructive pulmonary disease (COPD)...
DRG Epidemiology’s coverage of chronic obstructive pulmonary disease (COPD) comprise...
DRG Epidemiology’s coverage of chronic obstructive pulmonary disease (COPD)...
DRG Epidemiology’s coverage of chronic obstructive pulmonary disease (COPD) comprises epidemiological estimates of key patient populations in&n...
